“PNew research has concluded that severe vitamin D deficiency is an independent contributor to hospital and 1-year mortality in critically ill cancer patients, and that intensive care unit (ICU) survivors may benefit from supplementation.” [Source: nutraingredients.com]
There is abundant evidence that vitamin D deficiency contributes to the development of cancer and that an optimum intake of this essential micronutrient helps prevent it.
Recent research clearly shows that having a good vitamin D status can help protect against cancer. The use of vitamin D supplements is known to lower the risk of advanced cancer and also of dying from the disease.
Conversely, a deficiency of vitamin D has been linked to poor outcomes in Hodgkin’s lymphoma patients. Vitamin D deficiency is similarly associated with reduced survival in patients with multiple myeloma.
When used therapeutically, high-dose vitamin D has shown benefits in patients with advanced colorectal cancer. Vitamin D supplements have also been demonstrated to slow down and reverse the development of prostate cancer.
Reflecting their cutting-edge work on other diseases, scientists at the Dr. Rath Research Institute have published groundbreaking studies showing that obtaining optimum results in cancer requires the use of a synergistic combination of micronutrients. Illustrating this, in a study published in 2019 they found that combining vitamin D with other specific micronutrients can benefit breast cancer. Over the past two decades, their work has shown that synergistic combinations of micronutrients can inhibit the invasion of more than 40 different types of human cancer.
To read how Dr. Rath’s Cellular Medicine approach has been scientifically proven to block all key mechanisms that make cancer a deadly disease, check out the lifesaving book he authored with Dr. Aleksandra Niedzwiecki, ‘Victory Over Cancer’.